AKT1 and cancer: Matrine and oxymatrine modulate multiple signaling pathways involved in cancer progression, including the Wnt/β-catenin, PI3K/Akt, and NF-κB pathways, and exhibit anti-angiogenic effects, reducing the blood supply to tumors and inhibiting their growth and spread (Oh et al., 2023).